PTX 2.50% 3.9¢ prescient therapeutics limited

Ann: PTX-100 Ph1b results show excellent safety & efficacy in TCL, page-24

  1. 4,316 Posts.
    lightbulb Created with Sketch. 2019
    Pretty much the results published today would have been enough for an accelerated approval from a phase 2a trial.

    So they just have to keep replicating these results.

    Hopefully the next trial will see Ptx100 used as a second line of treatment drug,so results may even be better.

    Lots of de risking for the announcement today.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
-0.001(2.50%)
Mkt cap ! $31.40M
Open High Low Value Volume
4.0¢ 4.0¢ 3.8¢ $23.03K 590.2K

Buyers (Bids)

No. Vol. Price($)
2 25254 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 249836 2
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.